Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
2022 · Nature Medicine · 240 citations
https://doi.org/10.1038/s41591-022-01789-0
A
Anna E. A. Surace
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
642
Citations
7
h-index
6
i10-index
Anna E. A. Surace is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Chronic Lymphocytic Leukemia Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0001-9589-3005Papers by this author
worksDeep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis
2025 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-025-60987-9
R4RA molecular paper: RNAseq and metadata
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19336679
Additional file 2 of Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20295832
R4RA molecular paper: RNAseq and metadata
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19336679.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat